Drugs / Vaccinia Immune Globulin (Human)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00006630 | — | infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaccinia Immune Globulin (Human) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006630 ↗ |
| Known as | VIG | “VIG is purified from human blood and used to treat serious infections of the vaccinia (smallpox vaccine) virus or similar viruses.” NCT00006630 ↗ |
| Route | Intramuscular | “used for intramuscular injection” NCT00006630 ↗ |